Novavax to Host 3rd Annual Analyst and Investor Meeting
Senior management will conduct a series of presentations to update analysts and investors on the Company’s ongoing clinical development programs. In addition, a key opinion leader will provide a clinical perspective on respiratory syncytial virus (RSV) disease.
For additional information and registration, please email email@example.com or call 443-213-0506.
A live webcast link of the presentations will be available via the company website at novavax.com under “Investor Info”/ “Events”. Please allow extra time prior to the webcast to visit the site and download the streaming media software required to listen to the Internet broadcast. The event will be archived on the company's website for 90 days.
Novavax, Inc. Barclay A. PhillipsSVP, Chief Financial Officer and Treasurer Andrea N. Flynn, Ph.D. Senior Manager, Investor Relations firstname.lastname@example.org 240-268-2000 Russo Partners, LLC David Schull Todd Davenport, Ph.D. email@example.com firstname.lastname@example.org 212-845-4271